Opus Genetics, Inc.
IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31
Reports and events: 309 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-05-1309:01 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001140361-22-019002 |
| 2022-05-1308:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-018973 |
| 2022-04-2807:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-016342 |
| 2022-04-2709:07 ET | DEF 14A | Proxy statementPeriod 2022-06-13 | 0001140361-22-016115 |
| 2022-03-2908:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-011507 |
| 2022-03-2417:04 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001140361-22-011015 |
| 2022-03-2408:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-010857 |
| 2022-01-3109:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-003200 |
| 2022-01-3106:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-003143 |
| 2022-01-0507:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-000594 |
| 2021-11-1517:14 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-037932 |
| 2021-11-1208:31 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001140361-21-037545 |
| 2021-08-1216:54 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001140361-21-028115 |
| 2021-08-1207:31 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-028006 |
| 2021-06-3009:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-022830 |
| 2021-06-2316:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-21-022033 |
| 2021-06-0816:32 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-020180 |
| 2021-06-0716:05 ET | 8-K/A | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-020067 |
| 2021-06-0416:48 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-019927 |
| 2021-05-0716:39 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001140361-21-016458 |
| 2021-05-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-21-016430 |
| 2021-04-2616:05 ET | DEF 14A | Proxy statementPeriod 2021-06-07 | 0001140361-21-014256 |
| 2021-04-1216:20 ET | 8-K | 8.01 Other events | 0001140361-21-012441 |
| 2021-03-1509:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-21-008429 |
| 2021-03-1109:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-21-008135 |
| 2021-03-1108:34 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-21-008130 |
| 2021-03-1121:47 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001140361-21-008099 |
| 2021-02-0420:27 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-21-006591 |
| 2021-01-0607:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-21-000300 |
| 2020-12-3017:13 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-20-029928 |
| 2020-11-2516:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001140361-20-026607 |
| 2020-11-1716:44 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-20-025827 |
| 2020-11-0609:18 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001140361-20-024749 |
| 2020-11-0306:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-20-024376 |
| 2020-10-2907:04 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001140361-20-024042 |
| 2020-10-0916:03 ET | 8-K | 8.01 Other events | 0001140361-20-022798 |
| 2020-09-1106:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-20-020176 |
| 2020-09-0207:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-20-019615 |
| 2020-08-1407:30 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001140361-20-018406 |
| 2020-08-0307:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-20-017238 |
| 2020-07-0108:37 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001140361-20-015244 |
| 2020-06-1909:02 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-20-014267 |
| 2020-05-0707:10 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001140361-20-010906 |
| 2020-04-2907:01 ET | 10-K/A | Annual report, amendedPeriod 2019-12-31 | 0001140361-20-010048 |
| 2020-04-0906:15 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-20-008410 |
| 2020-03-1616:30 ET | 8-K | 1.01 Entry into a material agreement | 0001140361-20-005875 |
| 2020-02-2116:39 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001140361-20-003785 |
| 2020-02-1016:54 ET | 8-K | 8.01 Other events | 0001140361-20-002721 |
| 2019-11-0617:01 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001140361-19-019932 |
| 2019-08-2916:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-19-015801 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:22 ET. Listed shows no prices and gives no investment advice.